C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Nabriva Therapeutics Receives Positive EU CHMP Opinion for XENLETA™ (lefamulin) for the Treatment of Community-Acquired Pneumonia (CAP)

Saturday, May 30, 2020

Nabriva Therapeutics plc announced that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA has adopted a positive opinion recommending approval of XENLETA lefamulin for the treatment of communityacquired pne...

Johnson & Johnson Receives Positive CHMP Opinion for Janssen’s Investigational Preventive Ebola Vaccine Regimen

Saturday, May 30, 2020

Johnson Johnson announced that its Janssen Pharmaceutical Companies received a positive opinion from the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA for its investigational Ebola vaccine regimen for the p...

Merck Expands Emprove® Portfolio with Chromatography Resins

Friday, May 29, 2020

Merck has expanded its Emprove Portfolio with its Fractogel Eshmuno and ProSep chromatography resins providing comprehensive product information to facilitate and accelerate selection qualification risk assessment and support regulatory filings These...

Vetter Wins Axia Best Managed Companies Award

Friday, May 29, 2020

A look at vital figures makes it clear that Vetter is a very successful globally active Contract Development and Manufacturing Organization CDMO Over the last ten years the company has more than doubled its annual sales revenues to approximately mil...

Premier Inc. ProvideGx™ Program Partners with Hikma Pharmaceuticals to Secure the Supply of Two Drugs Essential for COVID-19 Patient Care

Friday, May 29, 2020

Premier Inc through its ProvideGx program has partnered with Hikma Pharmaceuticals PLC Hikma Group to supply amiodarone and sterile water to healthcare providers helping to stabilize the longterm supply of two medications vital for COVID patient care

FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer's Disease

Friday, May 29, 2020

The US Food and Drug Administration approved Tauvid flortaucipir F for intravenous injection the first drug used to help image a distinctive characteristic of Alzheimers disease in the brain called tau pathology Tauvid is a radioactive diagnostic age...

Rentschler Biopharma Extends Collaboration with Genmab to U.S. facility

Thursday, May 28, 2020

Rentschler Biopharma SE a leading global contract development and manufacturing organization CDMO for biopharmaceuticals announced today that the company has entered into a strategic collaboration with Genmab for the process development and manufactu...

Microbion Corporation Announces Orphan Drug Designation Granted for Pravibismane Suspension for Inhalation by US FDA

Thursday, May 28, 2020

Microbion Corporation of Bozeman MT and Microbion Pharma Corp of Vancouver BC Microbion announced that the US FDA has granted orphan drug designation for inhalation delivery of pravibismane BisEDT antimicrobial suspension for treatment management of...

Sensei Biotherapeutics Completes Acquisition of Alvaxa Biosciences, a Camelid Antibody Therapeutics Company

Thursday, May 28, 2020

Sensei Biotherapeutics Inc a clinicalstage biopharmaceutical company developing precision immunooncology therapies announced the acquisition of Alvaxa Biosciences Inc a camelid antibody therapeutics company with technology licensed from Fred Hutchins...

Protara Therapeutics Receives Fast Track Designation from U.S. FDA for Intravenous Choline Chloride for the Treatment of Intestinal Failure Associated Liver Disease

Wednesday, May 27, 2020

Protara Therapeutics Inc a clinical stage company developing treatments for rare and specialty diseases with significant unmet needs announced that the US Food and Drug Administration FDA has granted Fast Track designation to Intravenous IV Choline C...